Seelos Therapeutics Inc. (SEEL) is priced at $1.77 after the most recent trading session. At the very opening of the session, the stock price was $1.58 and reached a high price of $1.79, prior to closing the session it reached the value of $1.50. The stock touched a low price of $1.46.
Recently in News on December 21, 2020, Seelos Therapeutics Announces Issuance of a Patent for Trehalose (SLS-005) in Israel. Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has been issued Israeli patent number 241757 by the State of Israel Patent Office titled: “TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE”. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Seelos Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.7900 on 12/21/20, with the lowest value was $0.4195 for the same time period, recorded on 04/02/20.
Seelos Therapeutics Inc. (SEEL) full year performance was 30.15%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Seelos Therapeutics Inc. shares are logging 4.12% during the 52-week period from high price, and 321.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.42 and $1.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4389331 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Seelos Therapeutics Inc. (SEEL) recorded performance in the market was 32.09%, having the revenues showcasing 184.61% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 93.93M, as it employees total of 6 workers.
Seelos Therapeutics Inc. (SEEL) in the eye of market guru’s
During the last month, 0 analysts gave the Seelos Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9118, with a change in the price was noted +0.5200. In a similar fashion, Seelos Therapeutics Inc. posted a movement of +41.60% for the period of last 100 days, recording 1,444,943 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SEEL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Seelos Therapeutics Inc. (SEEL): Stocks Technical analysis and Trends
Raw Stochastic average of Seelos Therapeutics Inc. in the period of last 50 days is set at 98.13%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 98.04%. In the last 20 days, the company’s Stochastic %K was 98.00% and its Stochastic %D was recorded 94.92%.
If we look into the earlier routines of Seelos Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 32.09%. Additionally, trading for the stock in the period of the last six months notably improved by 43.90%, alongside a boost of 30.15% for the period of the last 12 months. The shares increased approximately by 38.28% in the 7-day charts and went down by 119.25% in the period of the last 30 days. Common stock shares were driven by 184.61% during last recorded quarter.